To prohibit certain uses of xylazine, and for other purposes.

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Bill 119 HR 1266, also known as the "Xylazine Prohibition Act," aims to restrict the use of xylazine for certain purposes. Xylazine is a sedative commonly used in veterinary medicine, but it has also been misused as a recreational drug and in criminal activities.

The bill prohibits the use of xylazine for non-medical purposes, such as in the production or distribution of illicit drugs. It also prohibits the use of xylazine in any form of animal fighting, including cockfighting and dogfighting.

Additionally, the bill includes provisions for increased penalties for individuals found in violation of the xylazine prohibition. This includes fines and potential imprisonment for those caught using xylazine for illegal purposes. Overall, the Xylazine Prohibition Act seeks to address the misuse of xylazine and protect both animals and communities from the harmful effects of its misuse.